Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites

Thromb Haemost. 2022 Mar;122(3):353-362. doi: 10.1055/a-1515-9529. Epub 2021 Jul 4.

Abstract

Development of ascites is the most common form of decompensation of cirrhosis. We aimed to investigate the coagulation system in ascitic fluid and plasma of patients with cirrhosis. We determined coagulation parameters and performed clotting and fibrinolysis experiments in ascitic fluid and plasma of thoroughly characterized patients with cirrhosis and ascites (n = 25) and in plasma of patients with cirrhosis but without ascites (n = 25), matched for severity of portal hypertension. We also investigated plasma D-dimer levels in an independent cohort of patients (n = 317) with clinically significant portal hypertension (HVPG ≥ 10 mmHg), grouped according to ascites severity. Ascitic fluid was procoagulant in a clotting assay. The procoagulant potential of ascitic fluid was abolished by depletion of extracellular vesicles from ascitic fluid by filtration or by addition of a tissue factor-neutralizing antibody. Compared with plasma, extracellular vesicle-associated tissue factor activity was high in ascitic fluid, while activities of other coagulation factors were low. The extracellular vesicle-depleted fraction of ascitic fluid induced fibrinolysis, which was prevented by aprotinin, indicating the presence of plasmin in ascitic fluid. Plasma peak thrombin generation and parameters reflecting fibrinolysis were independently associated with the presence of ascites. Finally, plasma D-dimer levels were independently linked to ascites severity in our second cohort comprising 317 patients. In conclusion, coagulation and fibrinolysis become activated in ascites of patients with cirrhosis. While tissue factor-exposing extracellular vesicles in ascitic fluid seem unable to pass the peritoneal membrane, fibrinolytic enzymes get activated in ascitic fluid and may re-enter the systemic circulation and induce systemic fibrinolysis.

MeSH terms

  • Ascites* / blood
  • Ascites* / diagnosis
  • Ascites* / etiology
  • Ascitic Fluid / metabolism*
  • Austria / epidemiology
  • Blood Coagulation Factors* / analysis
  • Blood Coagulation Factors* / metabolism
  • Blood Coagulation Tests / methods
  • Blood Coagulation Tests / statistics & numerical data
  • Cohort Studies
  • Correlation of Data
  • Disease Progression
  • Female
  • Fibrin Fibrinogen Degradation Products / antagonists & inhibitors
  • Fibrinolysis
  • Humans
  • Hypertension, Portal* / blood
  • Hypertension, Portal* / diagnosis
  • Liver Cirrhosis* / blood
  • Liver Cirrhosis* / epidemiology
  • Liver Cirrhosis* / physiopathology
  • Male
  • Middle Aged
  • Severity of Illness Index

Substances

  • Blood Coagulation Factors
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D